Literature DB >> 15781878

Carcinoma of the esophagus: is biology screaming in my deaf ears?

Jaffer A Ajani.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15781878     DOI： 10.1200/JCO.2005.12.911

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Genetic variants in CHEK1 gene are associated with the prognosis of thoracic esophageal squamous cell carcinoma patients treated with radical resection.

Authors:  Jing Li; Yang Tang; Liu Huang; Qian-Qian Yu; Guang-Yuan Hu; Chao Chen; Peng Zhang; Xiang-Lin Yuan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

2.  p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.

Authors:  David W Cescon; Penelope A Bradbury; Kofi Asomaning; Jessica Hopkins; Rihong Zhai; Wei Zhou; Zhaoxi Wang; Matthew Kulke; Li Su; Clement Ma; Wei Xu; Ariela L Marshall; Rebecca Suk Heist; John C Wain; Thomas J Lynch; David C Christiani; Geoffrey Liu
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

3.  Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma.

Authors:  R C Fields; V E Strong; M Gönen; K A Goodman; N P Rizk; D P Kelsen; D H Ilson; L H Tang; M F Brennan; D G Coit; M A Shah
Journal:  Br J Cancer       Date:  2011-05-24       Impact factor: 7.640

4.  Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection.

Authors:  Jing Li; Yang Tang; Liu Huang; Qianqian Yu; Guangyuan Hu; Xianglin Yuan
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

5.  1H-NMR based metabonomic profiling of human esophageal cancer tissue.

Authors:  Liang Wang; Jie Chen; Longqi Chen; Pengchi Deng; Qian Bu; Pu Xiang; Manli Li; Wenjie Lu; Youzhi Xu; Hongjun Lin; Tianming Wu; Huijuan Wang; Jing Hu; Xiaoni Shao; Xiaobo Cen; Ying-Lan Zhao
Journal:  Mol Cancer       Date:  2013-04-04       Impact factor: 27.401
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.